Literature DB >> 8690906

Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase.

W W Kwok1, M L Domeier, F C Raymond, P Byers, G T Nepom.   

Abstract

Polymorphic residues of HLA class II molecules influence immune activation in part by determining specific structural constraints for binding antigenic peptides. We identified a peptide from glutamic acid decarboxylase, a diabetes-associated autoantigen that preferentially bound to HLA-DQ3.2 molecules, one of the HLA determinants highly associated with insulin-dependent diabetes. We analyzed interactions of specific HLA-DQ residues with modified peptide analogues and found a pattern of permissive site-specific amino acids that accommodated allele-specific binding. Four anchor residues constrain binding to different DQ alleles; limited variation at two of these sites, residues 4 and 9, accounts for the unique pattern of peptide binding to HLA-DQ3.1 or HLA-DQ3.2.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8690906

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.

Authors:  G K Papadopoulos; C Wijmenga; F Koning
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

3.  Identification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologies.

Authors:  Maria Fiorella Mazzeo; Beatrice De Giulio; Stefania Senger; Mauro Rossi; Antonio Malorni; Rosa Anna Siciliano
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

Review 4.  Molecular aspects of type 1 diabetes.

Authors:  M A Kelly; M L Rayner; C H Mijovic; A H Barnett
Journal:  Mol Pathol       Date:  2003-02

5.  Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.

Authors:  Anish Suri; James J Walters; Michael L Gross; Emil R Unanue
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

6.  The production and crystallization of the human leukocyte antigen class II molecules HLA-DQ2 and HLA-DQ8 complexed with deamidated gliadin peptides implicated in coeliac disease.

Authors:  Kate N Henderson; Hugh H Reid; Natalie A Borg; Sophie E Broughton; Trevor Huyton; Robert P Anderson; James McCluskey; Jamie Rossjohn
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-11-21

7.  Modifying Enzymes Are Elicited by ER Stress, Generating Epitopes That Are Selectively Recognized by CD4+ T Cells in Patients With Type 1 Diabetes.

Authors:  Meghan L Marre; John W McGinty; I-Ting Chow; Megan E DeNicola; Noah W Beck; Sally C Kent; Alvin C Powers; Rita Bottino; David M Harlan; Carla J Greenbaum; William W Kwok; Jon D Piganelli; Eddie A James
Journal:  Diabetes       Date:  2018-04-13       Impact factor: 9.461

8.  HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.

Authors:  Stig Tollefsen; Helene Arentz-Hansen; Burkhard Fleckenstein; Oyvind Molberg; Melinda Ráki; William W Kwok; Günther Jung; Knut E A Lundin; Ludvig M Sollid
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

9.  Induction of insulitis by glutamic acid decarboxylase peptide-specific and HLA-DQ8-restricted CD4(+) T cells from human DQ transgenic mice.

Authors:  L Wen; F S Wong; L Burkly; M Altieri; C Mamalaki; D Kioussis; R A Flavell; R S Sherwin
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

10.  Autoantibody epitopes to the smaller isoform of glutamate decarboxylase do not differ in Swedish and Japanese type 1 diabetes patients and may be associated with high-risk human leucocyte antigen class II alleles.

Authors:  T Maruyama; S Oak; T R Hall; J P Banga; E Ortqvist; R A Ettinger; J Endl; C S Hampe
Journal:  Clin Exp Immunol       Date:  2007-10-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.